Myotoxic reactions to lipid-lowering therapy are associated with altered oxidation of fatty acids

Endocrine

Volumn 35, Issue 1, 2009, Pages 38-46

  Phillips, Paul S ^a   Ciaraldi, Theodore P ^b,c   Kim, Dong Lim ^b,c,d   Verity, M Anthony ^e   Wolfson, Tanya ^f,g   Henry, Robert R ^b,c  

^a SCRIPPS MERCY HOSPITAL   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d Konkuk University School of Medicine   (South Korea)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Scripps Mercy Clinical Research Center   (United States)

Author keywords

Complications; Fatty acids; Lipids; Myotubes; Statins

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CERIVASTATIN; EZETIMIBE; FATTY ACID; FLUINDOSTATIN; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOVASTATIN PLUS NICOTINIC ACID; MEVINOLIN; NICOTINIC ACID; OCTANOIC ACID; PALMITIC ACID; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; FATTY ACID OXIDATION; FEMALE; HUMAN; HUMAN CELL CULTURE; KNEE ARTHROPLASTY; MALE; MUSCLE BIOPSY; MUSCLE CRAMP; MUSCLE DISEASE; MUSCLE FATIGUE; MUSCLE WEAKNESS; MYALGIA; MYOPATHY; MYOTUBE; PRIORITY JOURNAL; SKELETAL MUSCLE; BIOPSY; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET RESTRICTION; DRUG EFFECT; EXERCISE TEST; METABOLISM; MIDDLE AGED; MUSCLE; OXIDATION REDUCTION REACTION; PATHOLOGY; PHYSIOLOGY;

AGED; ANTILIPEMIC AGENTS; BIOPSY; CELLS, CULTURED; EXERCISE TEST; FASTING; FATTY ACIDS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLES; MUSCULAR DISEASES; OXIDATION-REDUCTION;

EID: 63449088307     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-008-9126-2     Document Type: Article

References (39)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001 JAMA 285 2486 2497
2. KA Foley RJ Simpson Jr JR Crouse III TW Weiss LE Markson CM Alexander 2003 Am. J. Cardiol. 9 79 81
3. JG O'Meara SL Kardia JJ Armon CA Brown E Boerwinkle ST Turner 2004 Arch. Intern. Med. 164 1313 1318
4. RC Pasternak SC Smith Jr CN Bairey-Merz SM Grundy JI Cleeman C Lenfant 2002 Stroke 33 2337 2341
5. BJ Barker RR Goodenough JM Falko 2003 Diabetes Care 26 2482 2483
6. T Langer RI Levy 1968 N. Engl. J. Med. 279 856 858
7. SC Litin CF Anderson 1989 Am. J. Med. 86 481 483
8. GJ Magarian LM Lucas C Colley 1991 Arch. Intern. Med. 151 1873 1874
9. PS Phillips RH Haas S Bannykh S Hathaway NL Gray BJ Kimura GD Vladutiu JD England 2002 Ann. Intern. Med. 137 581 585
10. PS Phillips RH Haas S Bannykh S Hathaway NL Gray BJ Kimura GD Vladutiu JDF England 2002 Atheroscler. Thromb. Vasc. Biol. Online Journal 22 878
11. JE Carroll MH Brooke DC DeVivo KK Kaiser JM Hagberg 1978 Muscle Nerve 1 103 110
12. G Paolisso M Barbagallo G Petrella E Ragno M Barbieri M Giordano M Varricchio 2000 Atherosclerosis 150 121 127
13. PS Phillips CT Phillips MJ Sullivan RK Naviaux RH Haas The Scripps Mercy Research Center 2004 Atherosclerosis 177 183 188
14. RR Henry L Abrams S Nikoulina TP Ciaraldi 1995 Diabetes 44 936 946
15. M Gaster I Petersen K Hojlund P Poulsen H Beck-Nielsen 2002 Diabetes 51 921 927
16. RR Henry TP Ciaraldi L Brams-Carter S Mudaliar KS Park SE Nikoulina 1996 J. Clin. Invest. 98 1231 1236
17. BS Cha TP Ciaraldi KS Park LL Carte S Mudaliar RR Henry 2005 Am. J. Physiol. Endocrinol. Metab. 298 E151-E159
18. FX Kleber G Vietzke KD Wernecke U Bauer C Opitz R Wensel A Sperfeld S Gläser 2000 Circulation 101 2803 2809
19. K Wasserman 1997 Chest 112 1091 1101
20. CB Cooper WL Beaver DM Cooper K Wasserman 1992 Exp. Physiol. 77 51 64
21. V. Dubowitz (ed.), Muscle Biopsy: A Practical Approach (Bailliere Tindall, London, 1985)
22. HY Pan AR DeVault D Wang-Iverson E Ivashkiv BN Swanson AA Sugerman 1990 J. Clin. Pharmacol. 30 1128 1135
23. SA Holstein HR Knapp GH Clamon DJ Murry RJ Hohl 2006 Cancer Chemother. Pharmacol. 57 155 164
24. R Rognstad 1991 Biochem. J. 279 147 150
25. T Brun F Assimacopoulos-Jeannet BE Corkey M Prentki 1997 Diabetes 46 393 400
26. MM Bradford 1976 Anal. Biochem. 72 248 254
27. M Lofberg H Jankala A Paetau M Harkonen H Somer 1998 Acta Neurol. Scand. 98 268 275
28. GD Vladutiu Z Simmons PJ Isackson M Tarnopolsky WL Peltier AC Barboi N Sripathi RL Wortmann PS Phillips 2006 Muscle Nerve 34 153 162
29. Diabetes Atorvastin Lipid Intervention (DALI) Study Group 2001 Diabetes Care 24 1335 1341
30. WL Isley WS Harris JM Miles 2006 Metabolism 55 758 762
31. J Hanai P Cao P Taksale S Imamura E Koshimizu S Kishi PS Phillips SH Lecker VP Sukhatme 2007 J. Clin. Invest. 117 3940 3951
32. RT Jagoe AL Goldberg 2001 Curr. Opin. Clin. Nutr. Metab. Care 4 183 190
33. MD Gomes SH Lecker RT Jagoe A Navon AL Goldberg 2001 Proc. Natl. Acad. Sci. USA 98 14440 14445
34. RS Rosenson 2004 Am. J. Med. 116 408 416
35. DM Muoio JM Way CJ Tanner DA Winegar SA Kliewer JA Houmard WE Kraus GL Dohm 2002 Diabetes 51 901 909
36. M Guzman JP Cortes J Castro 1993 Lipids 1087 1093
37. G Martin H Duez C Blanquart 2001 J. Clin. Invest. 107 1423 1432
38. I Inoue F Itoh S Aoyagi 2002 Biochem. Biophys. Res. Commun. 290 131 139
39. T Maiguma K Fujisaki Y Itoh 2003 Naunyn Schmiedebergs Arch. Pharmacol. 367 289 296